| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35561-249-13 | 35561-249 | HUMAN PRESCRIPTION DRUG | Fenofibrate | Fenofibrate | TABLET, FILM COATED | ORAL | 20210101 | N/A | ANDA | ANDA208476 | AustarPharma, LLC | FENOFIBRATE | 48 mg/1 | 500 TABLET, FILM COATED in 1 BOTTLE (35561-249-13) |
| 35561-249-10 | 35561-249 | HUMAN PRESCRIPTION DRUG | Fenofibrate | Fenofibrate | TABLET, FILM COATED | ORAL | 20210101 | N/A | ANDA | ANDA208476 | AustarPharma, LLC | FENOFIBRATE | 48 mg/1 | 30 TABLET, FILM COATED in 1 BOTTLE (35561-249-10) |
| 35561-250-10 | 35561-250 | HUMAN PRESCRIPTION DRUG | Fenofibrate | Fenofibrate | TABLET, FILM COATED | ORAL | 20210101 | N/A | ANDA | ANDA208476 | AustarPharma, LLC | FENOFIBRATE | 145 mg/1 | 30 TABLET, FILM COATED in 1 BOTTLE (35561-250-10) |
| 35561-250-13 | 35561-250 | HUMAN PRESCRIPTION DRUG | Fenofibrate | Fenofibrate | TABLET, FILM COATED | ORAL | 20210101 | N/A | ANDA | ANDA208476 | AustarPharma, LLC | FENOFIBRATE | 145 mg/1 | 500 TABLET, FILM COATED in 1 BOTTLE (35561-250-13) |